Results 31 to 40 of about 63,797 (281)

Impact of Drug Pressure versus Limited Access to Drug in Malaria Control: The Dilemma

Medicines, 2022
Malaria burden has severe impact on the world. Several arsenals, including the use of antimalarials, are in place to curb the malaria burden. However, the application of these antimalarials has two extremes, limited access to drug and drug pressure ...
Chinedu Ogbonnia Egwu, Nwogo Ajuka Obasi, Chinyere Aloke, Joseph Nwafor, Ioannis Tsamesidis, Jennifer Chukwu, Sunday Elom   +6 more
doaj   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

, 2022
Hepatology, EarlyView.
Robert J. Fontana, Iris Liou, Adrian Reuben, Ayako Suzuki, M. Isabel Fiel, William Lee, Victor Navarro   +6 more
wiley   +1 more source

Acute Kidney Injury in a Patient Receiving Antimalarial Therapy: A Case Report

Haseki Tıp Bülteni, 2020
In this article, we present a case of Plasmodium falciparum malaria in a male patient who developed acute kidney injury during antimalarial treatment.
Heval Can Bilek, Aydın Deveci, Esra Tanyel   +2 more
doaj   +1 more source

The 15-Months Clinical Experience of SARS-CoV-2: A Literature Review of Therapies and Adjuvants

Antioxidants, 2021
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus responsible for the coronavirus disease of 2019 (COVID-19) that emerged in December 2019 in Wuhan, China, and rapidly spread worldwide, with a daily increase in ...
Alessio Danilo Inchingolo, Gianna Dipalma, Angelo Michele Inchingolo, Giuseppina Malcangi, Luigi Santacroce, Maria Teresa D’Oria, Ciro Gargiulo Isacco, Ioana Roxana Bordea, Sebastian Candrea, Antonio Scarano, Benedetta Morandi, Massimo Del Fabbro, Marco Farronato, Gianluca Martino Tartaglia, Mario Giosuè Balzanelli, Andrea Ballini, Ludovica Nucci, Felice Lorusso, Silvio Taschieri, Francesco Inchingolo   +19 more
doaj   +1 more source

Poor-quality antimalarials further health inequities in Uganda

Health Policy and Planning, 2019
Substandard and falsified medications are a major threat to public health, directly increasing the risk of treatment failure, antimicrobial resistance, morbidity, mortality and health expenditures.
Daniel R. Evans, Colleen R Higgins, Sarah K. Laing, Phyllis Awor, S. Ozawa   +4 more
semanticscholar   +1 more source

Modeling the Economic Impact of Substandard and Falsified Antimalarials in the Democratic Republic of the Congo.

American Journal of Tropical Medicine and Hygiene, 2019
Substandard and falsified medicines pose significant risks to global health, including increased deaths, prolonged treatments, and growing drug resistance.
S. Ozawa, Deson Haynie, Sophia Bessias, Sarah K. Laing, E. Ngamasana, T. Yemeke, Daniel R. Evans   +6 more
semanticscholar   +1 more source

Hydroxychloroquine‐induced erythema multiforme

Clinical Case Reports, 2020
Hydroxychloroquine is a commonly used medication and rarely may result in development of erythema multiforme. This potential cutaneous side effect should be highlighted in information given to patients prior to hydroxychloroquine commencement.
Dimitra Koumaki, Vasiliki Koumaki, George Bertsias, Sotirios Boumpoucheropoulos, Alexander Katoulis, Maria Stefanidou, Orestis Miaris, George Evangelou, Kyriaki Zografaki, Sabine Elke Krueger‐Krasagakis, Konstantinos Krasagakis   +10 more
doaj   +1 more source

Blood schizontocidal activity of methylene blue in combination with antimalarials against Plasmodium falciparum

Parasite, 2007
Methylene blue (MB) is the oldest synthetic antimalarial. It is not used anymore as antimalarial but should be reconsidered. For this purpose we have measured its impact on both chloroquine sensitive and resistant Plasmodium strains.
Garavito G., Bertani S., Rincon J., Maurel S., Monje M.C., Landau I., Valentin A., Deharo E.   +7 more
doaj   +1 more source

In vitro drug interaction of ionophores with artemisinin and chloroquine against Plasmodium falciparum 3D7 blood-stage infection

Frontiers in Drug Discovery, 2023
The prevalence of clinical resistance of P. falciparum towards artemisinin and its partner drugs has significantly hampered malarial chemotherapy. To circumvent this situation, identifying a new class of partner drugs with significant anti-malarial ...
Vinoth Rajendran, Keerthana Gurukkalot
doaj   +1 more source

Developing and Evaluating a Laboratory‐Based Frailty Index for the Prediction of Long‐Term Health Outcomes in Systemic Lupus Erythematosus

Arthritis Care &Research, EarlyView.
Objective We aimed to construct and evaluate the first laboratory‐based frailty index (FI‐Lab) for predicting adverse outcomes in systemic lupus erythematosus (SLE) and to compare its predictive ability to that of an existing clinical FI. Methods We used data from a single‐center prospective cohort of adult patients with SLE whose baseline visit ...
Grace Burns, Samuel D. Searle, Alexandra Legge   +2 more
wiley   +1 more source